Answers are grounded in this paper and cite their sources.
Background: Neutrophil activation and neutrophil extracellular traps (NETs) participate in downstream microvascular thromboinflammation (DMT) and blood brain barrier disruption in acute ischemic stroke (AIS). Objectives: The aim of this study was to test whether deoxyribonuclease 1 (DNase 1) infusion, which cleaves extracellular DNA, could reduce DMT in a transient middle cerebral artery (MCA) occlusion stroke model in rats. Methods: Eighteen rats were subjected to 120-minute transient MCA occlusion. DNase 1 (3 mg/kg, 20% intravenous, and 80% intraperitoneal injection) or vehicle were randomly infused 30 minutes after MCA occlusion. Main outcome criteria were the infarct volume assessed with magnetic resonance imaging, neurological disability, and the rate of hemorrhagic transformation measured at 24 hours. Brain DMT was assessed with biomarkers of platelet, coagulation, and neutrophil activation quantified in brain homogenates. Results: = .031, respectively). Conclusion: Our results confirm that NETs contribute to DMT during AIS and that early NET-targeting therapy may represent a new strategy to improve the clinical benefit of large vessel recanalization in AIS.
No takes yet. Share an insight, caveat, or question.
Meglio et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: